English
Français
Español
General
Contacts
Documents
UNSPSC
Revisions
General information
Request for EOI
5th Invitation to RH Medicines Manufacturers to submit EOI for Product Evaluation by WHO ERP
United Nations Population Fund
UNFPA/DNK/EOI/14/001
06-Jan-2014
28-Feb-2014 17:00
(GMT +1.00) Brussels, Copenhagen, Madrid, Paris

UNFPA is inviting Expressions of Interest (EOIs) from eligible suppliers in respect to the provision of Reproductive Health Medicines for product evaluation by the WHO Expert Review Panel (ERP). 

Countries
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Cyprus
Czech Republic
Congo, The Democratic Republic of the
Denmark
Djibouti
Dominica
Dominican Republic
Timor-Leste
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, the former Yugoslav Republic
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russian Federation
Rwanda
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
Tanzania, United Republic of
United States of America
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U. S.
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe
Antarctica
Palestine, State of
Serbia, Republic of
Montenegro
Kosovo
South Sudan
Isabel Lucas Manzano - manzano@unfpa.org, Tel: +45 4533 7274
manzano@unfpa.org
Isabel
Lucas Manzano
Denmark (+45)
4533 7274
Isabel Lucas Manzano - manzano@unfpa.org, Tel: +45 4533 7274
Seloi Mogatle - mogatle@unfpa.org, Tel: +45 4533 7277
mogatle@unfpa.org
Seloi
Mogatle
Denmark (+45)
4533 7277
Seloi Mogatle - mogatle@unfpa.org, Tel: +45 4533 7277
QUESTIONNAIRE_Word Format.docx (show)
EOI ERP_06_January_2013.pdf (show)
E - Medical, Laboratory & Test Equipment & Supplies & Pharmaceuticals
51000000 - Drugs and Pharmaceutical Products
51180000 - Hormones and hormone antagonists
51181800 - Estrogens and progestins and internal contraceptives
51210000 - Miscellaneous drug categories
There have been no revisions to this notice.
View this message in English.